Publications of M. Ising
All genres
Meeting Abstract (13)
301.
Meeting Abstract
29, pp. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. (2019)
Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 302.
Meeting Abstract
126 (11), pp. 1522 - 1523. International Congress of the
World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Wurzburg, GERMANY, October 03, 2019 - October 05, 2019. (2019)
Interactions between FKBP5 variation and environmental stressors in adolescent major depression. In JOURNAL OF NEURAL TRANSMISSION, 303.
Meeting Abstract
66 (1), p. 119 - 119. (2019)
Evidence of a prothrombotic Condition in Patients with a remitted Depression. In ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 304.
Meeting Abstract
88, p. 134 - 134. 25th World Congress of the
International-College-of-Psychosomatic-Medicine (ICPM) on Psychosomatic
Medicine, Florence, ITALY, September 11, 2019 - September 13, 2019. (2019)
Evidence for an enhanced procoagulant state in remitted major depression. In PSYCHOTHERAPY AND PSYCHOSOMATICS, 305.
Meeting Abstract
71 (S), p. 73 - 73. 46th Annual Conference of the
International-Society-of-Psychoneuroendocrinology - Personalized
Medicine in the Neurosciences - Genetics, Imaging, and Hormones, Miami, FL, September 08, 2016 - September 11, 2016. (2016)
Hair cortisol in maltreated children and adolescents: Importance of developmental period and maltreatment characteristics. In PSYCHONEUROENDOCRINOLOGY, 306.
Meeting Abstract
61 Special Issue Ed., PO94, p. 56 - 56. 45th Annual Meeting of the International-Society-of-Psychoneuroendocrinology (ISPNE) on Stress and
the Brain - From Fertility to Senility, Edinburgh, SCOTLAND, September 08, 2015 - September 11, 2015. Elsevier BV, Amsterdam (2015)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach. In PSYCHONEUROENDOCRINOLOGY, 307.
Meeting Abstract
17, RA-01-003, p. 42 - 42. 29th CINP World Congress of Neuropsychopharmacology
, Vancouver, Canada, June 22, 2014 - June 26, 2014. Oxford University Press, Oxford, UK (2014)
Genetic predictor of antidepressant response for major depressive disorder accounting for clinical subgroups: A genome-wide association study. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 308.
Meeting Abstract
75 (9), p. 23S - 23S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
ABCB1 Genotyping Informs the Clinician About Adequacy of Antidepressant Dosing. In BIOLOGICAL PSYCHIATRY, 309.
Meeting Abstract
122 (3), P046. 57th Symposium of the German Society of Endocrinology, Dresden, March 19, 2014 - March 22, 2014. Georg Thieme Verlag, Stuttgart, Germany (2014)
Sleep characteristics in transsexuals receiving cross-sex hormone treatment. In EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 310.
Meeting Abstract
75 (9), p. 45S - 45S. 69th Annual Scientific Convention and Meeting of the
Society-of-Biological-Psychiatry, New York, NY, May 08, 2014 - May 10, 2014. Elsevier Science Inc., New York, NY, USA (2014)
RNA Expression Profiling in Age-/Severity-Matched Depressed Inpatients Revealed New Candidates as Possible Biomarkers for Antidepressant Response. In BIOLOGICAL PSYCHIATRY, Other (1)
311.
Other
Hypothalamic-Pituitary-Adrenocortical Axis Activity as a Potential Predictor for Withdrawal Symptoms in Addiction to Flupirtine, a Nonopiate Analgesic [Letter], JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 34, pp. E6 - E8 (2014)
Book Review (1)
312.
Book Review
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System-V1b-antagonists as a Case in Point. PHARMACOPSYCHIATRY (2024)